Anna A. Schwendeman,Yuqing Eugene Chen,Yanhong Guo,Jifeng Zhang,Wenmin Yuan,Emily Morin
申请号：
US15561372
公开号：
US20180250419A1
申请日:
2016.03.25
申请国别(地区):
US
年份:
2018
代理人:
摘要：
The present invention relates to nanoparticles complexed with therapeutic agents configured for treating cardiovascular related disorders, and methods of synthesizing the same. In particular, the present invention is directed to compositions comprising synthetic HDL (sHDL) nanoparticles carrying therapeutic agents configured for treating cardiovascular related disorders, methods for synthesizing such sHDL nanoparticles, as well as systems and methods utilizing such sHDL nanoparticles (e.g., in diagnostic and/or therapeutic settings (e.g., for the delivery of therapeutic agents, imaging agents, and/or targeting agents (e.g., in cardiovascular disease diagnosis and/or therapy, etc.))).
